← Back
$ACRS All transactions

Aclaris Therapeutics, Inc.

M

$ Value

$0

Shares

26,750

Price

$0

Filed

Dec 4

Insider

Name

Davis Hugh M.

Title

President and COO

CIK

0002045027

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-02

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

80,250

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. | The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of December 2, 2024 (in each case rounded down to the nearest whole share, except for the last vesting installment), subject to the Continuous Service (as defined in the Issuer's 2024 Inducement Plan) of the Reporting Person as of each such date.

Filing Info

Accession No.

0002045027-25-000003

Form Type

4

Issuer CIK

0001557746

Davis Hugh M.'s History

Date Ticker Type Value
2026-02-03 ACRS M
2026-02-03 ACRS M $0
2026-02-02 ACRS A $0
2026-02-02 ACRS A $0
2025-12-02 ACRS M
2025-12-02 ACRS M $0

Other Insiders at ACRS (90d)

Insider Bought Sold Last
Walker Neal
CEO
2026-02-03
Loerop James
Chief Business Officer
2026-02-03
Balthaser Kevin
Chief Financial Officer
2026-02-03
Davis Hugh M.
President and COO
2026-02-03
Hall Jesse Wayne
Chief Medical Officer
2026-02-02
Kolbeck Roland Wilhelm
Chief Scientific Officer
2026-02-02